Primary hyperparathyroidism during  pregnancy – current approach

Magdalena  Kochman

doi:10.36553/wm.66

Published: 2020-12-21

Vol. 2 No. 2 (2020)

Primary hyperparathyroidism during pregnancy – current approach

Magdalena Kochman

Wiedza Medyczna

Section: Review papers

https://doi.org/10.36553/wm.66

Abstract

Primary hyperparathyroidism (PHPT) during pregnancy is a rare, but may cause many maternal and fetal complications. Most cases are mild and very often remain undiagnosed throughout the whole pregnancy period, especially since its symptoms overlap those occurring in normal pregnancy. Additionally, physiological changes in calcium metabolism and PTH secretion may make the diagnosis difficult. Some current data indicate, that in pregnant women with mild PHPT the risk of obstetrical complications do not increase. However, according to others some complications, including miscarriage, intrauterine growth retardation or preeclampsia continue to occur even in subjects with mild hypercalcemia or those previously successfully treated for PHPT. Additionally, the course of PHPT during pregnancy may exacerbate, and rapid severe worsening of hypercalcemia may occur in the postpartum period. Parathyroidectomy, optimally performed during the second trimester, remains the main and the only definite treatment of PHPT, especially, when the serum calcium level exceeds 2,75 mmol/l. In patients with mild, asymptomatic PHPT some experts recommend conservative treatment with postponing surgery to the postpartum period. There are no medical guidelines regarding the treatment of PHPT during pregnancy. Therefore, to achieve optimal care of pregnant women with PHPT, they should be diagnosed, monitored and treated in reference centers by multidisciplinary teams of closely cooperating specialists. Conservative treatment is possible only on condition of close monitoring of the mother and child during pregnancy and after delivery.

Keywords:

primary hyperparathyroidism, pregnancy, parathormone, hypercalcemia

Download files

PDF

Citation rules

Kochman, M. . (2020). Primary hyperparathyroidism during pregnancy – current approach. Wiedza Medyczna, 2(2), 77–83. https://doi.org/10.36553/wm.66

Cited by / Share

References

(1) Khan AA, Hanley DA, Rizzoli R, et al. Primary hyperparathyroidism: review and recommendations on evaluation, diagnosis, and management. A Canadian and international consensus. Osteoporos Int 2017; 28(1):1-19. DOI:10.1007/s00198-016-3716-2.
Google Scholar

(2) Abood A, Vestergaard P. Pregnancy outcomes in women with primary hyperparathyroidism. Eur J Endocrinol 2014; 171(1):69-76. DOI:10.1530/EJE-13-0966.
Google Scholar

(3) Kovacs CS. Maternal mineral and bone metabolism during pregnancy, lactation, and post-weaning recovery. Physiol Rev 2016; 96(2):449-547.
Google Scholar

(4) Gillies BR, Ryan BA, Tonkin BA, Poulton IJ, Ma Y, Kirby BJ, St-Arnaud R, Sims NA, Kovacs CS. Absence of calcitriol causes increased lactational bone loss and lower milk calcium but does not impair post-lactation bone recovery in Cyp27b1 null mice. J Bone Miner Res 2018; 33:16-26.
Google Scholar

(5) Kovacs CS. Calcium and phosphate metabolism and related disorders during pregnancy and lactation. [Updated 2018 Dec 4]. In: Feingold KR, Anawalt B, Boyce A, et al., editors. Endotext. South Dartmouth (MA): MDText.com, [Inc.]: 2000. https://www.ncbi.nlm.nih.gov/books/NBK279173/.
Google Scholar

(6) Diaz-Soto G, Linglart A, Sénat MV, et al. Primary hyperparathyroidism in pregnancy. Endocrine 2013; 44(3):591-7. DOI:10.1007/s12020-013-9980-4.
Google Scholar

(7) Abbassi-Ghanavati M, Greer LG, Cunningham FG. Pregnancy and laboratory studies: a reference table for clinicians. Obstetrics and Gynecology. 2009 Dec; 114(6):1326-1331. DOI:10.1097/aog.0b013e3181c2bde8.
Google Scholar

(8) Winter EM, Appelman-Dijkstra NM. Parathyroid hormone-related protein-induced hypercalcemia of pregnancy successfully reversed by a dopamine agonist. J Clin Endocrinol Metab 2017; 102(12):4417-4420. DOI:10.1210/jc.2017-01617.
Google Scholar

(9) Delvin EE, Glorieux FH, Salle BL, David L, Varenne JP. Control of vitamin D metabolism in preterm infants: feto-maternal relationships. Arch Dis Child 1982; 57(10):754-757. DOI:10.1136/adc.57.10.754.
Google Scholar

(10) Kovacs CS. Bone development and mineral homeostasis in the fetus and neonate: roles of the calciotropic and phosphotropic hormones. Physiol Rev 2014; 94(4):1143-218. DOI:10.1152/physrev.00014.2014.
Google Scholar

(11) Shani H, Sivan E, Cassif E, Simchen MJ. Maternal hypercalcemia as a possible cause of unexplained fetal polyhydramnion: a case series. Am J Obstet Gynecol 2008; 199(4):410.e1-5. DOI:10.1016/j.ajog.2008.06.092.
Google Scholar

(12) Schnatz PF, Thaxton S. Parathyroidectomy in the third trimester of pregnancy. Obstet Gynecol Surv 2005; 60:672-682. DOI:10.1097/01.ogx.0000180889.23678.fb.
Google Scholar

(13) Berger C, Almohareb O, Langsetmo L, et al. Characteristics of hyperparathyroid states in the Canadian multicentre osteoporosis study (CaMos) and relationship to skeletal markers. Clin Endocrinol (Oxf) 2015; 82:359-68. DOI:10.1111/cen.12569.
Google Scholar

(14) Norman J, Politz D, Politz L. Hyperparathyroidism during pregnancy and the effect of rising calcium on pregnancy loss: a call for earlier intervention. Clin Endocrinol (Oxf) 2009; 71(1):104-9. DOI:10.1111/j.1365-2265.2008.03495.x.
Google Scholar

(15) DiMarco AN, Meeran K, Christakis I, et al. Seventeen Cases of Primary Hyperparathyroidism in Pregnancy: A Call for Management Guidelines. J Endocr Soc 2019; 3(5):1009-1021. DOI:10.1210/js.2018-00340.
Google Scholar

(16) Hirsch D, Kopel V, Nadler V, et al. Pregnancy outcomes in women with primary hyperparathyroidism. J Clin Endocrinol Metab 2015; 100(5):2115-22. DOI:10.1210/jc.2015-1110.
Google Scholar

(17) Walker A, Fraile JJ, Hubbard JG. "Parathyroidectomy in pregnancy" – a single centre experience with review of evidence and proposal for treatment algorithim. Gland Surg 2014; 3(3):158-164. DOI:10.3978/j.issn.2227-684X.2014.02.04.
Google Scholar

(18) Nilsson IL, Adner N, Reihnér E, et al. Primary hyperparathyroidism in pregnancy: a diagnostic and therapeutic challenge. J Womens Health (Larchmt) 2010; 19(6):1117-21. DOI:10.1089/jwh.2009.1777.
Google Scholar

(19) Wermers RA, Khosla S, Atkinson EJ, et al. Incidence of primary hyperparathyroidism in Rochester, Minnesota, 1993-2001: an update on the changing epidemiology of the disease. J Bone Miner Res 2006 Jan; 21(1):171-7. DOI:10.1359/JBMR.050910.
Google Scholar

(20) OECD Family Database http://www.oecd.org/els/family/database.htm.
Google Scholar

(21) Cassir G, Sermer C, Malinowski AK. Impact of Perinatal Primary Hyperparathyroidism on Maternal and Fetal and Neonatal Outcomes: Retrospective Case Series. J Obstet Gynaecol Can 2020 Mar 29. DOI:10.1016/j.jogc.2019.12.017.
Google Scholar

(22) Sullivan SA. Parathyroid Diseases. Clin Obstet Gynecol 2019; 62(2):347-358. DOI:10.1097/GRF.0000000000000447.
Google Scholar

(23) Blanco LT, Socarras MR, Montero RF, et al. Renal colic during pregnancy: Diagnostic and therapeutic aspects. Literature review. Cent European J Urol 2017; 70(1):93-100. DOI:10.5173/ceju.2017.754.
Google Scholar

(24) Yang J, Dong MJ, Chen F. A rare lethal case of severe acute necrotizing pancreatitis due to a parathyroid adenoma in a third-trimester pregnant woman. BMC Endocr Disord 2019; 19(1):82. Published 2019 Jul 29. DOI:10.1186/s12902 -019-0409-9.
Google Scholar

(25) Han ES, Fritton K, Bacon P, et al. Preterm Parturient with Polyhydramnios and Pancreatitis: Primary Presentation of Hyperparathyroidism. Case Rep Obstet Gynecol 2018; 2018:2091082. DOI:10.1155/2018/2091082.
Google Scholar

(26) Stahl J, Winters N, Shariff A. A rare case of primary hyperparathyroidism, hyperemesis gravidarum, and Wernicke encephalopathy. AACE Clin Case Rep 2018; 5(2):e108-e111. DOI:10.4158/ACCR-2018-0286.
Google Scholar

(27) Krysiak R, Wilk M, Okopien B. Recurrent pancreatitis induced by hyperparathyroidism in pregnancy. Arch Gynecol Obstet 2011; 284(3):531-534. DOI:10.1007/s00404-010-1668-x.
Google Scholar

(28) DiMarco A, Christakis I, Constantinides V, Regan L, Palazzo FF. Undiagnosed Primary Hyperparathyroidism and Recurrent Miscarriage: The First Prospective Pilot Study. World J Surg 2018; 42(3):639-645. DOI:10.1007/s00268-017-4395-7.
Google Scholar

(29) Kelly TR. Primary hyperparathyroidism during pregnancy. Surgery 1991; 10:1028-1034.
Google Scholar

(30) Hultin H, Hellman P, Lundgren E, et al. Association of parathyroid adenoma and pregnancy with preeclampsia. J Clin Endocrinol Metab 2009; 94(9):3394-9. DOI:10.1210/jc.2009-0012.
Google Scholar

(31) Pothiwala P, Levine SN. Parathyroid surgery in pregnancy: review of the literature and localization by aspiration for parathyroid hormone levels. J Perinatol 2009; 29(12):779-784.
Google Scholar

(32) Tachamo N, Timilsina B, Dhital R, et. al. Primary Hyperparathyroidism in Pregnancy: Successful Parathyroidectomy during First Trimester. Case Rep Endocrinol 2018; 2018:5493917. DOI:10.1155/2018/5493917.
Google Scholar

(33) Rubin MR, Silverberg SJ. Use of Cinacalcet and 99mTc-sestamibi Imaging During Pregnancy. J Endocr Soc 2017; 1(9):1156-1159. DOI:10.1210/js.2017-00308.
Google Scholar

(34) McMullen TP, Learoyd DL, Williams DC, et al. Hyperparathyroidism in pregnancy: options for localization and surgical therapy. World J Surg 2010; 34(8):1811-6. DOI:10.1007/s00268-010-0569-2.
Google Scholar

(35) Malheiro E, Chabbert-Buffet N, Talbot JN, Périé S. Hyperparathyroidism in pregnancy and 99mTc-MIBI scintigraphy. Eur Ann Otorhinolaryngol Head Neck Dis 2019; 136(6):501-503. DOI:10.1016/j.anorl.2019.05.009.
Google Scholar

(36) American College of Obstetricians and Gynecologists' Committee on ObstetricPractice. CommitteeOpinion No. 656: Guidelines for Diagnostic Imaging During Pregnancy and Lactation. Obstet Gynecol 2016; 127(2):e75-80. DOI:10.1097/AOG.0000000000001316.
Google Scholar

(37) Cetani F, Saponaro F, Marcocci C. Non-surgical management of primary hyperparathyroidism. Best Pract Res Clin Endocrinol Metab 2018; 32(6):821-835. DOI:10.1016/j.beem.2018.09.006.
Google Scholar

(38) Schnatz PF, Curry SL. Primary hyperparathyroidism in pregnancy: evidence-based management. Obstet Gynecol Surv 2002; 57:365-376. DOI:10.1097/00006254-200206000-00022.
Google Scholar

(39) Hu Y, Cui M, Sun Z, et al. Clinical Presentation, Management, and Outcomes of Primary Hyperparathyroidism during Pregnancy. Int J Endocrinol 2017; 2017:3947423. DOI:10.1155/2017/3947423.
Google Scholar

(40) Komarowska H, Bromińska B, Luftmann B, Ruchała M. Primary hyperparathyroidism in pregnancy – a review of literature. Ginekol Pol 2017; 88(5):270-275. DOI:10.5603/GP.a2017.0051.
Google Scholar

(41) Zhang Y, Ding JW, Yu LY, et al. Twin pregnancy with triple parathyroid adenoma: A case report and review of literature. World J Clin Cases. 2018; 6(11):466-471. DOI:10.12998/wjcc.v6.i11.466.
Google Scholar